Avalo Therapeutics Inc (AVTX)
10.84
-0.65
(-5.66%)
USD |
NASDAQ |
May 10, 16:00
10.79
-0.05
(-0.46%)
After-Hours: 18:17
Avalo Therapeutics Shareholders Equity (Quarterly): 7.304M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.304M |
| September 30, 2023 | 14.70M |
| June 30, 2023 | -6.969M |
| March 31, 2023 | -6.267M |
| December 31, 2022 | -10.92M |
| September 30, 2022 | -2.028M |
| June 30, 2022 | -5.951M |
| March 31, 2022 | 6.343M |
| December 31, 2021 | 23.08M |
| September 30, 2021 | 40.31M |
| June 30, 2021 | 21.59M |
| March 31, 2021 | 33.16M |
| December 31, 2020 | 24.56M |
| September 30, 2020 | 38.57M |
| June 30, 2020 | 50.58M |
| March 31, 2020 | 25.59M |
| December 31, 2019 | 21.00M |
| September 30, 2019 | 18.22M |
| June 30, 2019 | 17.70M |
| Date | Value |
|---|---|
| March 31, 2019 | 23.12M |
| December 31, 2018 | 20.91M |
| September 30, 2018 | 19.51M |
| June 30, 2018 | 19.22M |
| March 31, 2018 | 24.58M |
| December 31, 2017 | 27.86M |
| September 30, 2017 | 22.12M |
| June 30, 2017 | 3.136M |
| March 31, 2017 | -0.4258M |
| December 31, 2016 | 0.207M |
| September 30, 2016 | 0.5868M |
| June 30, 2016 | 5.571M |
| March 31, 2016 | 8.881M |
| December 31, 2015 | 13.08M |
| September 30, 2015 | -32.85M |
| June 30, 2015 | -2.324M |
| March 31, 2015 | -29.52M |
| December 31, 2014 | -26.33M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-10.92M
Minimum
Dec 2022
50.58M
Maximum
Jun 2020
16.34M
Average
18.22M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
| Imunon Inc | 13.39M |
| iBio Inc | 9.197M |
| Kodiak Sciences Inc | 265.78M |
| Petros Pharmaceuticals Inc | 12.48M |
| Ocugen Inc | 40.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.99M |
| Total Liabilities (Quarterly) | 13.69M |
| Current Ratio | 1.818 |
| Net Debt Paydown Yield | 52.27% |